All articles by Patrick Brusnahan
Patrick Brusnahan
Editor of Private Banker International.
ABN AMRO signs life insurance strategic partnership in France
This life insurance partnership with ABN AMRO will lead to a distribution agreement and the sale of Neuflize vie to BNP Paribas Cardif.
PVcomBank transforms mobile banking with Temenos Digital and AWS
Vietnam-based PVcomBank has launched PVConnect to offer a modern and user-friendly mobile banking service that has gained positive reviews.
Hedge funds prioritising fundraising over the next year
More than half (55%) of hedge funds said that they expect to increase fundraising going into 2025.
Delta Capita names US head of client lifecycle management
Based in New York, Girao-Tavares will lead client lifecycle management in the region for Delta Capita.
Vontobel launches client-backed Swiss equity fund
The Vontobel Fund – Sustainable Swiss Equity Income Plus is an actively managed, diversified, and sustainable option.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
J. Safra Sarasin Group launches J. Safra Sarasin – Strategic Advisors
The business will focus on tailored advisory capabilities across services such as strategic advisory, M&A execution, capital structure advisory, and equity capital raising.
How can AI improve back-office operations?
Currently, the UK has an AI workforce which is equivalent to around 50,000 humans.
William Blair bolsters Philadelphia team
Fernberger comes with managing director and wealth adviser James Fernberger, as well as Alex and Zach Fernberger, both managing directors and wealth advisers as well.
BlackRock expands climate infrastructure team in New Zealand
Effective in July 2024, this follows BlackRock’s goal to launch a New Zealand focused strategy last year.
Blackstone announces plans to take I’rom Group private
I’rom provides clinical trial management services to pharmaceutical, biotechnology, and medical institutions. It also plays a critical role in the success of clinical trials, ensuring that technologies and medicines are brought to the market properly.